Aller au contenu

Publications scientifiques

  • article Fleury M, Roy J, Maltais R, Durocher F, Poirier D

    Aminosteroid RM-581 Induces G0/G1 Arrest and Endoplasmic Reticulum Stress-Mediated Apoptosis in Human Acute and Chronic Leukemia Cell Lines

    Cancers (Basel) 18 (7), 2026.

  • article Desmarais F, Maltais R, Sancéau JY, Marcotte B, Guèvremont G, Trottier J, Mitchell PL, Barbier O, Poirier D, Marette A

    A New Synthetic Analogue of Protectin DX With Enhanced Therapeutic Potential Against Metabolic-Associated Steatotic Liver Disease

    FASEB J 39 (20), 2025.

  • article Poirier D, Jutras M, Maltais R, Roy J, Fleury M

    Metabolite profiling in human and mouse liver microsomes of the aminosteroid RM-581, a new orally active anticancer agent

    Bioorg Chem 165 2025.

  • article Abed Y, Rhéaume C, Carbonneau J, Fortin N, Maltais R, Marette A, Poirier D, Boivin G

    Evaluation of combining the PDX analogue AN-137B with oseltamivir in a mouse model of severe influenza A (H1N1) infection

    Antivir Ther 30 (6), 2025.

  • article Poirier D

    Recent advances in the development of 17beta-hydroxysteroid dehydrogenase inhibitors

    Steroids 213 2025.

  • article Maltais R, de Sainte Maresville D, Desrosiers V, Poirier D

    Development of a Multigram Synthetic Route to RM-581, an Orally Active Aminosteroid Derivative Against Several Types of Cancers

    Molecules 30 (11), 2025.

  • article Sancéau JY, Maltais R, Zhou M, Lin SX, Poirier D

    Synthesis and characterization of targeted 17β-hydroxysteroid dehydrogenase type 7 inhibitors

    J Steroid Biochem Mol Biol 242 2024.

  • article Sancéau JY, Gaudreau É and Maltais R, Poirier D

    A simple and convenient synthesis of labeled 9-hydroxy[13C6]phenanthrene as internal standard for mass spectrometry quantification of a key phenanthrene metabolite in human urines

    Synth Commun 54 (3), 2024.

    DOI
  • article Kariminezhad Z, Rahimi M, Fernandes J, Maltais R, Sancéau JY, Poirier D, Fahmi H, Benderdour M

    Development of New Resolvin D1 Analogues for Osteoarthritis Therapy: Acellular and Computational Approaches to Study Their Antioxidant Activities

    Antioxidants (Basel) 13 (4), 2024.

  • article Fortin N, Hénaut M, Goyette N, Maltais R, Sancéau JY, Marette A, Poirier D, Abed Y, Boivin G

    A protectin DX (PDX) analog with in vitro activity against influenza A(H1N1) viruses

    J Med Virol 96 (3), 2024.

  • article Carleton N, Lee S, Li R, Zou J, Brown DD, Hooda J, Chang A, Kumar R, Klei LR, Rigatti LH, Newsome J, John Mary DJS, Atkinson JM, West RE, Nolin TD, Oberly PJ, Huang Z, Poirier D, Diego EJ, Lucas PC, Tseng G, Lotze MT, McAuliffe PF, Zervantonakis IK, Oesterreich S, Lee AV

    Systemic and local chronic inflammation and hormone disposition promote a tumor-permissive environment for breast cancer in older women

    bioRxiv 2024.

  • article Rusnac R, Garbuz O, Kravtsov V, Melnic E, Istrati D, Tsapkov V, Poirier D, Gulea A

    Novel Copper(II) Coordination Compounds Containing Pyridine Derivatives of N4-Methoxyphenyl-Thiosemicarbazones with Selective Anticancer Activity

    Molecules 29 (24), 2024.